Skip Navigation


Carcinogenesis Advance Access originally published online on December 8, 2005
Carcinogenesis 2006 27(4):772-781; doi:10.1093/carcin/bgi297
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/4/772    most recent
bgi297v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kim, S.
Right arrow Articles by Rappaport, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.
Right arrow Articles by Rappaport, S. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism

Sungkyoon Kim, Roel Vermeulen 1, Suramya Waidyanatha, Brent A. Johnson, Qing Lan 1, Nathaniel Rothman 1, Martyn T. Smith 2, Luoping Zhang 2, Guilan Li 3, Min Shen 1, Songnian Yin 3 and Stephen M. Rappaport *

School of Public Health, University of North Carolina, Chapel Hill, NC 27599, USA, 1 National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, MD 20892, USA, 2 School of Public Health, University of California, Berkeley, CA 94720, USA and 3 Chinese Center for Disease Control and Prevention, Beijing, China

* To whom correspondence should be addressed at: CB 7431, School of Public Health, University of North Carolina, Chapel Hill, NC 27599, USA. Tel: +1 919 966 5017; Fax: +1 919 966 0521; Email: stephen_rappaport{at}unc.edu

Although the toxicity of benzene has been linked to its metabolism, the dose-related production of metabolites is not well understood in humans, particularly at low levels of exposure. We investigated unmetabolized benzene in urine (UBz) and all major urinary metabolites [phenol (PH), E,E-muconic acid (MA), hydroquinone (HQ) and catechol (CA)] as well as the minor metabolite, S-phenylmercapturic acid (SPMA), in 250 benzene-exposed workers and 139 control workers in Tianjin, China. Median levels of benzene exposure were ~1.2 p.p.m. for exposed workers (interquartile range: 0.53–3.34 p.p.m.) and 0.004 p.p.m. for control workers (interquartile range: 0.002–0.007 p.p.m.). (Exposures of control workers to benzene were predicted from levels of benzene in their urine.) Metabolite production was investigated among groups of 30 workers aggregated by their benzene exposures. We found that the urine concentration of each metabolite was consistently elevated when the group's median benzene exposure was at or above the following air concentrations: 0.2 p.p.m. for MA and SPMA, 0.5 p.p.m. for PH and HQ, and 2 p.p.m. for CA. Dose-related production of the four major metabolites and total metabolites (µmol/l/p.p.m. benzene) declined between 2.5 and 26-fold as group median benzene exposures increased between 0.027 and 15.4 p.p.m. Reductions in metabolite production were most pronounced for CA and PH <1 p.p.m., indicating that metabolism favored production of the toxic metabolites, HQ and MA, at low exposures.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Zhang, X. Tang, N. Rothman, R. Vermeulen, Z. Ji, M. Shen, C. Qiu, W. Guo, S. Liu, B. Reiss, et al.
Occupational Exposure to Formaldehyde, Hematotoxicity, and Leukemia-Specific Chromosome Changes in Cultured Myeloid Progenitor Cells
Cancer Epidemiol. Biomarkers Prev., January 1, 2010; 19(1): 80 - 88.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L.-C. Lin, W.-J. Chen, Y.-M. Chiung, T.-S. Shih, and P.-C. Liao
Association between GST Genetic Polymorphism and Dose-Related Production of Urinary Benzene Metabolite Markers, trans, trans-Muconic Acid and S-Phenylmercapturic Acid
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1460 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
S. Suna, T. Hirao, F. Asakawa, T. Suzue, T. Mannami, and F. Jitsunari
Possible sources of urinary benzene among nonoccupationally exposed Japanese subjects
Toxicology and Industrial Health, April 1, 2008; 24(3): 155 - 160.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Kim, R. Vermeulen, S. Waidyanatha, B. A. Johnson, Q. Lan, M. T. Smith, L. Zhang, G. Li, M. Shen, S. Yin, et al.
Modeling Human Metabolism of Benzene Following Occupational and Environmental Exposures.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2246 - 2252.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.